Results 131 to 140 of about 12,377 (185)

Applications of Artificial Intelligence in Alpha-1 Antitrypsin Deficiency: A Systematic Review from a Respiratory Medicine Perspective. [PDF]

Medicina (Kaunas)
Casal-Guisande M, Villar-Aguilar L, Fernández-Villar A, García-Rodríguez E, Casal A, Torres-Durán M.   +5 more
europepmc   +1 more source

Alpha-1 antitrypsin deficiency with the rare IZ phenotype presenting as cystic lung disease. [PDF]

BMJ Case Rep
Reed TJ, Shisler R, Collins J.
europepmc   +1 more source

Next-Generation Regenerative Therapies for Alpha-1 Antitrypsin Deficiency: Molecular Pathogenesis to Clinical Translation. [PDF]

Int J Mol Sci
Yang SR, Kim HR.
europepmc   +1 more source

Alpha-1-antitrypsin deficiency

, 2013
openaire   +1 more source

Clinical Utility of Non-Invasive Tests for Liver Fibrosis in People Living With Alpha-1 Antitrypsin Deficiency. [PDF]

Liver Int
Boeckmans J, Schattenberg JM, Fromme M, Strnad P, Hagström H.   +4 more
europepmc   +1 more source

Percutaneous Microwave Ablation of Hepatocellular Carcinoma As Bridge-to-Transplant Therapy in a High-Risk Patient With Alpha-1 Antitrypsin Deficiency and Factor V Leiden Mutation: A Case Report. [PDF]

Cureus
Khan Z, Jafri M, Lambroussis CG, Khan Z, Khan M.   +4 more
europepmc   +1 more source

Assessing inflammatory protein biomarkers in COPD subjects with and without alpha-1 antitrypsin deficiency. [PDF]

Respir Res
Moll M, Hobbs BD, Pratte KA, Zhang C, Ghosh AJ, Bowler RP, Lomas DA, Silverman EK, DeMeo DL.   +8 more
europepmc   +1 more source

Alpha-1 antitrypsin deficiency: genetics, clinical manifestations, AI prognostics, and advanced imaging in liver disease. [PDF]

Ann Med Surg (Lond)
Rajab I, Marin MP, Shubietah A, Khaled A, Bdair M, Abukhalil MM, Jallad H, Hussein A, Aldwaik SA, Salvatore MM.   +9 more
europepmc   +1 more source

Further Insights into Emphysema Progression and Lung Function Decline in MZ Alpha-1 Antitrypsin Deficiency. [PDF]

Ann Am Thorac Soc
McElvaney OJ.
europepmc   +1 more source

A synergistic approach to curative liver therapy: multiplex CRISPR-Cas12a and repair drive for alpha-1 antitrypsin deficiency (AATD). [PDF]

Ann Med Surg (Lond)
Ullah I, Usman M, Saleem Y, Banerji P.
europepmc   +1 more source